Impact Factor Of Crystal Growth And Design

You've probably stared at a journal's metrics page more times than you'd like to admit. Practically speaking, maybe you're deciding where to submit your latest manuscript. So maybe you're building a tenure packet. Maybe you're just curious whether the hours you spent refining that crystal structure paper will land in a journal that "counts.

Crystal Growth & Design sits in a weird spot. It's an ACS journal — American Chemical Society — which carries weight. Here's the thing — it's not Nature. In real terms, it's not a niche specialty title nobody outside your subfield reads. But its impact factor has bounced around in ways that make people pause.

Here's what you actually need to know.

What Is Crystal Growth & Design

Crystal Growth & Design (CG&D) launched in 2001. And the scope is right there in the name: crystal growth mechanisms, crystal design principles, crystallization processes, and the resulting solid-state materials. And aCS publishes it. That covers a lot of ground — pharmaceuticals, semiconductors, metal-organic frameworks, proteins, energetic materials, you name it.

The journal publishes full articles, communications, and reviews. It's monthly. Open access option exists (ACS AuthorChoice), but most content sits behind a paywall unless your institution subscribes.

It's indexed in all the usual places: Web of Science, Scopus, PubMed, Chemical Abstracts. That matters more than people realize — if a journal isn't in Web of Science, it doesn't get an official Journal Impact Factor from Clarivate. CG&D has had one since early on.

The society journal factor

ACS journals behave differently than commercial publisher titles. Still, the society reinvests revenue. Editors are active researchers, not professional managing editors. Here's the thing — reviewers tend to be specialists who actually know the chemistry. That shows up in the review quality — usually thorough, sometimes painfully so.

But it also means the journal doesn't chase trends the way some commercial titles do. You won't see sudden special issues on whatever's hot this month just to juice citations. That's a feature, not a bug, but it affects the metrics.

Why the Impact Factor Matters (And When It Doesn't)

Let's be honest: you're here because someone — a PI, a hiring committee, a grant reviewer — cares about that number. The Journal Impact Factor (JIF) is the 2024 Clarivate metric: citations in 2024 to items published in 2022 and 2023, divided by the number of citable items published in those two years.

CG&D's 2023 JIF (released June 2024) landed around 3.Practically speaking, 6. The 2022 JIF was about 4.Because of that, 0. Even so, the 2021 JIF was roughly 4. 3. There's a downward trend.

Before you panic: most chemistry journals saw declines post-2021. The pandemic citation bubble was real. Everyone published more, cited more, and now we're normalizing. Here's the thing — a drop from 4. And 3 to 3. 6 over two years isn't a journal collapsing — it's the field settling.

What the number actually tells you

A JIF of 3.6 in materials chemistry / crystallography puts CG&D solidly in the middle tier. It's above most specialty crystallography journals. It's below the big general materials titles (Advanced Materials, JACS, Angewandte). It's comparable to Crystal Growth & Design's closest direct competitors — Journal of Crystal Growth, CrystEngComm, maybe Inorganic Chemistry for the overlap papers.

But here's what the JIF doesn't* tell you:

How many citations your specific paper* will get (the distribution is wildly skewed — a handful of papers grab most citations)
Whether your subfield's community reads it (protein crystallographers might prefer Acta Crystallographica D; MOF people might target JACS or Chem)
How fast the review process moves (JIF says nothing about speed)
Whether the journal's scope matches your work perfectly

I've seen papers in CG&D rack up 200+ citations. And the journal didn't change. I've seen solid papers sit at 5 citations after three years. The paper's relevance to active problems did.

How the Metrics Break Down

If you're the type who reads the full Journal Citation Reports entry, here's the landscape.

Citation distribution

CG&D publishes a lot of papers. We're talking 1,500+ articles per year recently. That denominator in the JIF formula is huge. A few highly cited reviews help, but they get diluted fast.

The 5-year impact factor usually runs higher than the 2-year — around 4.Methods papers especially. 2 for the 2023 reporting year. Crystallography work gets cited for years. That suggests papers in this field have a longer citation half-life. If you publish a solid crystallization protocol or a new polymorph screening technique, people will cite it five, seven, ten years later.

Immediacy index and cite score

The Immediacy Index (citations in the same year) is low — typically under 0.Even so, 5. That's normal for chemistry. Nobody cites a paper the month it publishes unless it's a preprint they've already read.

CiteScore (Scopus metric) usually tracks a bit higher than JIF — mid-4s recently. Scopus covers more journals and counts citations differently. If your institution uses CiteScore for evaluations, CG&D looks slightly better there.

Category ranking

In "Crystallography" category (Web of Science), CG&D typically ranks in the top 10-15 out of ~25-30 journals. In "Chemistry, Multidisciplinary," it's middle of the pack — 60th-80th percentile depending on the year. In "Materials Science, Multidisciplinary," similar story.

The category matters because some evaluation systems normalize by category. If your department uses "chemistry multidisciplinary" rankings, CG&D looks decent. If they use "crystallography" specifically, it looks stronger.

If you found this helpful, you might also enjoy what challenges did mae jemison face or what happens when water is heated.

Common Mistakes People Make With This Journal

Submitting the wrong paper type

CG&D gets a lot of submissions that belong elsewhere. A routine crystal structure of a known compound type with no new insight? That's Acta Crystallographica E or Crystals territory. Still, a purely computational prediction with no experimental validation? Maybe Crystal Growth & Design if the method is novel, but often Journal of Chemical Theory and Computation fits better.

The journal wants design* or growth* insight. " The "so what?On the flip side, not just "we crystallized this and here's the structure. " needs to be in the abstract.

Ignoring the review timeline

CG&D is not fast. Full review cycles of 3-4 months are common. If you need a paper out for a grant deadline in six weeks, this isn't your journal. Consider this: median time to first decision often runs 6-8 weeks. ACS Central Science or JACS Communications might be — but they'll reject 90% of submissions.

Plan accordingly. The thorough reviews are a feature, but they cost time.

Overlooking the open access cost

ACS AuthorChoice runs around $5,000 USD (discounted for ACS members). Many funders cover it. In real terms, many don't. If your grant requires immediate open access and won't pay, you're either paying out of pocket or accepting the 12-month embargo on the author manuscript. Check your funder policy before* submitting.

Treating it as a "backup journal"

This is the big one. People treat CG&D as their safety net after JACS or Angewandte rejects

Treating it as a “backup journal” is a costly misconception. When a manuscript is rejected from a flagship outlet, the instinct to dump it into the first respectable venue that accepts it often leads to a rushed submission that lacks the targeted narrative CG & D demands. The result is a paper that, while technically sound, fails to articulate the design‑or‑growth rationale that the journal prizes, and consequently receives a tepid review or a straight rejection despite the author’s optimism.

A more productive approach is to view CG & D not as a safety net but as a strategic outlet for manuscripts that explicitly address crystal‑engineering challenges—be they novel synthetic routes, predictive growth models, or innovative post‑synthetic modifications that reach new properties. When the work aligns with those criteria, the journal’s rigorous peer‑review process becomes an asset rather than a bottleneck, endowing the final article with a stamp of credibility that can be leveraged in grant proposals, tenure dossiers, and collaborative negotiations.

Alternatives worth considering

If the manuscript is primarily a structural report with limited design insight, a suite of specialized venues may be a better fit:

Acta Crystallographica Section E for routine structure elucidation.
Crystals (MDPI) for rapid communication of small‑molecule structures.
Crystal Growth & Design (the sister journal of CG & D) for studies that point out growth kinetics or nucleation mechanisms.
Journal of the American Chemical Society – Communications or ACS Central Science for breakthrough findings that merit broader, faster exposure, albeit with a higher rejection threshold.

Selecting the appropriate outlet early in the drafting stage saves time, preserves the manuscript’s narrative focus, and maximizes the probability of acceptance.

Practical take‑aways for authors

Match the story to the journal. underline how the work advances crystal‑growth theory, enables new functional materials, or solves a long‑standing synthetic bottleneck.
Budget for the APC early. If open‑access publication is mandatory, confirm funding sources or institutional discounts before the submission deadline.
Plan for timelines. Build a realistic schedule that accommodates the typical 8‑week first‑decision window and subsequent revisions; factor in additional time for data‑intensive reviewer requests.
put to work the review feedback. Treat the thorough critiques as an opportunity to sharpen the manuscript’s contribution, not merely as a hurdle to clear.
Strategic submission. Reserve CG & D for studies that genuinely demand its unique blend of crystallographic rigor and materials‑oriented perspective.

Conclusion

ACS Crystal Growth & Design occupies a distinctive niche at the intersection of rigorous structural chemistry and forward‑looking crystal‑engineering. Its reputation for methodological depth and high‑impact publications is well earned, but that very strength imposes specific expectations on authors. By recognizing the journal’s role within the broader publishing ecosystem—understanding its citation metrics, category standing, and the particular types of manuscripts it seeks—researchers can make informed decisions about when to aim for CG & D and when to steer their work toward more specialized venues.

When used deliberately, the journal offers more than a publication venue; it provides a platform that amplifies contributions capable of reshaping how crystals are grown, engineered, and ultimately applied. For those whose research aligns with that vision, CG & D remains an invaluable conduit to the scientific community, delivering both visibility and validation in a field where precision and purpose are inextricably linked.